Home » Topics » BioWorld Science

BioWorld Science
RSS

GNE-502 shows promising efficacy in breast tumor xenograft model

Nov. 24, 2021

SNS-101, an anti-VISTA antibody, potentiates anti-PD-1/PD-L1 antitumor immunity

Nov. 24, 2021

Researchers develop a nonhuman primate model of Parkinson's disease

Nov. 24, 2021

Sanyou presents SYZJ-001 bispecific antibody drug against COVID-19

Nov. 23, 2021

Guard reports preclinical data on ROSgard in animal models of sepsis

Nov. 23, 2021

KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer

Nov. 23, 2021

Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes

Nov. 23, 2021

Bristol Myers Squibb adds structurally diverse compounds to BET inhibitor candidates

Nov. 23, 2021

PTSD model developed in Jeju minipig

Nov. 23, 2021

Novel mouse model of focal limbic seizures with impaired behavior

Nov. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...